Similar articles

• Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study.

  Brignole M, Menozzi C, Gianfranchi L, Musso G, Mureddu R, Bottoni N, Lolli G. Brignole M, et al. Circulation. 1998 Sep 8;98(10):953-60. doi: 10.1161/01.cir.98.10.953. Circulation. 1998. PMID: 9737514 Clinical Trial.
• Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation.

  Davie A, McMurray J. Davie A, et al. Circulation. 1999 Jun 8;99(22):2966; author reply 2966-7. doi: 10.1161/01.cir.99.22.2966. Circulation. 1999. PMID: 10359745 No abstract available.
• Assessment of left ventricular pacing in patients with severe cardiac failure after atrioventricular node ablation and right ventricular pacing for permanent atrial fibrillation.

  Blanc JJ, Etienne Y, Gilard M. Blanc JJ, et al. Europace. 1999 Jan;1(1):47-8. doi: 10.1053/eupc.1998.0011. Europace. 1999. PMID: 11220540 No abstract available.
• Rate control in atrial fibrillation.

  Van Gelder IC, Rienstra M, Crijns HJ, Olshansky B. Van Gelder IC, et al. Lancet. 2016 Aug 20;388(10046):818-28. doi: 10.1016/S0140-6736(16)31258-2. Lancet. 2016. PMID: 27560277 Review.
• Catheter ablation for atrial fibrillation: a promising therapy for congestive heart failure.

  Patel D, Natale A, Di Biase L, Burkhardt JD, Wang Y, Sanchez JE, Horton RP, Khan M. Patel D, et al. Expert Rev Cardiovasc Ther. 2009 Jul;7(7):779-87. doi: 10.1586/erc.09.61. Expert Rev Cardiovasc Ther. 2009. PMID: 19589114 Review.